Increase text size
Decrease text size
A+
A-
Enter your search term here
Get search results
Skip Navigation
Skip to content
Toggle Menu
Products
Formulations
Shilpa Medicare Limited (Unit IV)
Shilpa Therapeutics Private Limited
API
(Active Pharmaceutical Ingredients)
Operations
Research & Development
R&D - Raichur
R&D - Bangalore
R&D - Biologics - Hubli
Manufacturing
API
Raichur Unit I (India)
Raichur Unit II (100% EOU)(India)
Loba Feinchemie GmbH (Austria)
Formulations
Jadcherla Unit
Hyderabad Unit-Shilpa Therapeutics
Quality
Responsibility
CSR
EHS
Investor Relations
Annual Report
Annual Return
Financial Report
Statutory Details
Polices and Codes
Related Party Transaction
Shareholding Pattern
Unpaid/Unclaimed Dividend
Board Committees
Notices/ Correspondence
Transfer of share to IEPFA
Dividend
Subsidiaries, Associates & Joint Venture
Investor Presentation/ Updates
Stock Exchange Intimations
Home
Business Development
Who We Are
Milestones
Vision & Values
Board Of Director
Our Team
Media
Press Releases
Awards
Accreditations
Careers
Contact
Locations
Enquiry
Quality Policy
Operations
Research & Development
R&D - Raichur
R&D - Bangalore
R&D - Biologics - Hubli
Manufacturing
API
Raichur Unit I (India)
Raichur Unit II (India)
Loba Feinchemie GmbH (Austria)
Formulations
Jadcherla Unit
Hyderabad Unit
Quality
